OpenAlex
PricingAboutJobs
Log inGet started
Work

Once-Daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study

HTML PDF

Year: 2012
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Gastroenterology
DOI: 10.1053/j.gastro.2012.08.003
Authors: William J. Sandborn, Simon Travis, Luigi Moro, Richard Jones, Theres Gautille, Robert Bagin, Michael Huang, Phil Yeung, E. David Ballard
Institutions: University of California San Diego, John Radcliffe Hospital, Cosmo Pharmaceuticals (Italy)
Language: English

Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Keywords: ulcerative colitis, remission induction, sustained-release tablets, 5-aminosalicylic acid, oral corticosteroids, endoscopic improvement, symptom resolution, hepatic first-pass metabolism, mild-to-moderate ulcerative colitis, adverse events, drug safety and tolerability
SDG: Good health and well-being

Open Access status: bronze

Funders: Abbott Laboratories, Pfizer, GlaxoSmithKline, Novartis, Procter and Gamble, Shire, Genentech, Takeda Oncology, Janssen Biotech
OpenAlex ID: W1975391202
FWCI: 21.69
Cites: 40
Cited by: 265
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms